FARSs

The exact nature of "FARSs" as a drug or therapeutic agent is unclear from the available information. It is being investigated in a clinical application study for the treatment of Anterior Disc Displacement with Reduction (ADDwR), a temporomandibular joint disorder. While the acronym "FARS" can refer to several medical concepts, including Phenylalanyl-tRNA synthetase and Fatty Acid Receptor Subtype A, there is no direct evidence linking these specific biological entities or their modulators to the treatment of ADDwR in the provided context or public databases. Therefore, its mechanism of action and specific modality remain undefined.